GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $50,000 | 0.0% | 1,150 | 0.0% | 0.02% | +14.3% |
| Q1 2022 | $50,000 | -2.0% | 1,150 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | +15.9% | 1,150 | 0.0% | 0.01% | +7.7% |
| Q3 2021 | $44,000 | -42.1% | 1,150 | -39.9% | 0.01% | -43.5% |
| Q2 2021 | $76,000 | +90.0% | 1,915 | +71.7% | 0.02% | +76.9% |
| Q1 2021 | $40,000 | -2.4% | 1,115 | 0.0% | 0.01% | -7.1% |
| Q4 2020 | $41,000 | -2.4% | 1,115 | 0.0% | 0.01% | -17.6% |
| Q3 2020 | $42,000 | -6.7% | 1,115 | 0.0% | 0.02% | +21.4% |
| Q2 2020 | $45,000 | +275.0% | 1,115 | +254.0% | 0.01% | +180.0% |
| Q1 2020 | $12,000 | -67.6% | 315 | -59.8% | 0.01% | -66.7% |
| Q4 2019 | $37,000 | +164.3% | 783 | +148.6% | 0.02% | +87.5% |
| Q3 2019 | $14,000 | -50.0% | 315 | -55.0% | 0.01% | -52.9% |
| Q2 2019 | $28,000 | -24.3% | 700 | -22.2% | 0.02% | -32.0% |
| Q1 2019 | $37,000 | – | 900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |